ATravelers' diarrhea
First line
Travelers' diarrhea
First line
In traveler's diarrhea in adults, loperamide cuts symptom duration by about 50%. In mild disease it is appropriate as start-of-illness monotherapy; in moderate-to-severe disease the antibiotic (azithromycin or a fluoroquinolone) is the primary agent and loperamide is added to it. Loperamide must not be taken in dysentery (bloody stool, high fever, or suspected invasive infection): slowing gut motility prolongs the illness and risks toxic megacolon. Not used in children under 12 in this setting.
Sources
- Journal of Travel Medicine: Guidelines for the prevention and treatment of travelers’ diarrhea: a graded expert panel report (2017)
- Travel Med Infect Dis: Systematic review of loperamide: No proof of antibiotics being superior to loperamide in treatment of mild/moderate travellers' diarrhoea. (2016)
- Clin Infect Dis: Trial Evaluating Ambulatory Therapy of Travelers' Diarrhea (TrEAT TD) Study: A Randomized Controlled Trial Comparing 3 Single-Dose Antibiotic Regimens With Loperamide. (2017)
- Journal of Travel Medicine: Loperamide Plus Azithromycin More Effectively Treats Travelers’ Diarrhea in Mexico than Azithromycin Alone (2007)
- Clinical Gastroenterology and Hepatology: Treatment of Travelers’ Diarrhea: Randomized Trial Comparing Rifaximin, Rifaximin Plus Loperamide, and Loperamide Alone (2007)
ICD-10: A09 · ICD-11: 1A40